J. Arabadjiev

Successful treatment with docetaxel plus nintedanib in a patient with lung adenocarcinoma and pulmonary fibrosis: A case report and literature review

Galina Kirova-Nedyalkova, Tanya Zlatanova, J. Arabadjiev, 2022, Frontiers in Oncology.

Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.

M. Petrova, K. Koynov, N. Conev, 2020, Bioscience trends.

Engaging European society at the forefront of cancer research and care

L. Maier-Hein, M. Boutros, E. Weiderpass, 2023, Molecular oncology.

Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting

N. Conev, I. Donev, M. Radanova, 2023, Cancer reports.

Alteration of Mesenchymal Stem Cells Isolated from Glioblastoma Multiforme under the Influence of Photodynamic Treatment

I. Angelov, G. Vasilev, D. Kyurkchiev, 2023, Current issues in molecular biology.